Nyxoah announced today that it filed a lawsuit against Inspire Medical Systems alleging the infringement of sleep apnea therapy patents.

Philips Respironics has issued another ventilator recall deemed the most serious type by the FDA as it may cause serious injury or death.

Despite media reports suggesting a fresh investigation, France has not initiated a new probe into Philips' recall of sleep ...

For a potentially serious medical condition, it’s remarkable how few people know they have obstructive sleep apnea (OSA). The good news is that for people with a diagnosis, there have never been more ...

People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous ...

Polaris Market Research recently published a research report on “Sleep Apnea Devices Market Share, Size, Trends & Industry Analysis Report, By Diagnostic Devices (PSG, Respiratory polygraphs, Pulse ...

Note this is an early release from the Annual Meeting of the European Association for the Study of Diabetes (EASD 2025, Vienna, 15-19 September). Please credit the meeting if using this material* ...

The research highlights an unsettling link between nighttime oxygen loss and long-term cognitive health. The team behind the ...

A post hoc analysis of three major clinical trials finds that CPAP therapy lowers the risk for cardiovascular events only in ...

Here are four of the latest recalls and corrections reported to the FDA.

There is currently no drug that treats sleep apnea. However, the third clinical trial of AD109 suggests there could be one in the future. Taylor Leamey wrote about all things wellness for CNET, ...